{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:56:02Z","timestamp":1787028962976,"version":"build-2736575974"},"reference-count":32,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Canadian Urological Association Scholarship Foundation Career Development Award"},{"name":"Quebec Network for Research on Aging"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background\/Objectives: Overactive bladder (OAB), common in elderly women, involves urgency, frequency, and nocturia, with complex phenotypes. The use of neurotrophins as non-invasive urinary biomarkers has been previously explored. The objective of this study was to assess the diagnostic and therapeutic utility of urinary biomarkers in a Canadian population of aging female OAB patients. Methods: We conducted a single-center prospective study of aging female patients diagnosed with OAB and age-matched healthy controls, where we conducted pre- and post-treatment assessments using a combination of clinical questionnaires, voiding diaries, and urinary biomarkers nerve growth factor (NGF), proform of NGF (proNGF), brain-derived neurotrophic factor (BDNF), proform of BDNF (proBDNF), and neurotrophin receptor p75 extracellular domain (p75ECD)) quantified using ELISA. Baseline and post-treatment urinary biomarker levels in OAB patients were compared with those of controls. Results: OAB patients and controls at baseline displayed significant differences in neurotrophin levels and in their ratios of mature\/precursors. In the post-treatment OAB cohort, only NGF and proNGF exhibited significant improvement correlating with clinical symptom relief. Biomarkers in non-responders remained unchanged, suggesting heterogeneity in therapeutic response. Conclusions: Urinary neurotrophins show promise as non-invasive diagnostic markers of OAB and monitoring treatment response in aging female patients. While this study focused on patients broadly diagnosed with OAB, future research should aim to classify OAB subtypes\u2014such as those based on urodynamic studies or underlying pathophysiology\u2014to better understand how urinary neurotrophins can differentiate between mechanisms like detrusor overactivity, detrusor underactivity, or bladder outlet obstruction. This will enhance their relevance in guiding personalized treatment strategies and predicting outcomes.<\/jats:p>","DOI":"10.3390\/metabo15070429","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:37:21Z","timestamp":1750739841000},"page":"429","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neurotrophins and Proneurotrophins as Biomarkers for Overactive Bladder Syndrome in Aging Females"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5720-8991","authenticated-orcid":false,"given":"Claudia","family":"Covarrubias","sequence":"first","affiliation":[{"name":"Lady Davis Institute, McGill University, Montreal, QC H3T1E2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe G.","family":"Cammisotto","sequence":"additional","affiliation":[{"name":"Lady Davis Institute, McGill University, Montreal, QC H3T1E2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysanne","family":"Campeau","sequence":"additional","affiliation":[{"name":"Lady Davis Institute, McGill University, Montreal, QC H3T1E2, Canada"},{"name":"Urology Department, Jewish General Hospital, Montreal, QC H3T1E2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JU.0000000000003985","article-title":"The AUA\/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder","volume":"212","author":"Cameron","year":"2024","journal-title":"J. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2217\/ahe.10.87","article-title":"Urinary Incontinence in the Aging Female: Etiology, Pathophysiology and Treatment Options","volume":"7","author":"Gomelsky","year":"2011","journal-title":"Aging Health"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Haylen, B., De Ridder, D., Freeman, R., Swift, S., Berghmans, B., Lee, J., Monga, A., Petri, E., Rizk, D., and Sand, P. (2010). An International Urogynecological Association (IUGA)\/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction. Textbook of Female Urology and Urogynecology, CRC Press. [3rd ed.].","DOI":"10.3109\/9781439807217-111"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/nau.24965","article-title":"Third-Line Therapy for Overactive Bladder in the Elderly: Nuances and Considerations","volume":"41","author":"Zillioux","year":"2022","journal-title":"Neurourol. Urodyn."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","article-title":"A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment","volume":"75","author":"Peyronnet","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What Are Biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/nau.23210","article-title":"Could Urinary Nerve Growth Factor Be a Biomarker for Overactive Bladder? A Meta-Analysis","volume":"36","author":"Sheng","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1007\/s00192-021-04945-1","article-title":"The Use of Urinary Biomarkers in the Diagnosis of Overactive Bladder in Female Patients. A Systematic Review and Meta-Analysis","volume":"32","author":"Tsiapakidou","year":"2021","journal-title":"Int. Urogynecol. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11884-017-0406-7","article-title":"The Aging Overactive Bladder: A Review of Aging-Related Changes from the Brain to the Bladder","volume":"12","author":"Suskind","year":"2017","journal-title":"Curr. Bladder Dysfunct. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00192-024-05809-0","article-title":"Nerve Growth Factor and Brain-Derived Neurotrophic Factor as Potential Biomarkers of Mirabegron Efficacy in Patients with Overactive Bladder Syndrome","volume":"35","author":"Beta","year":"2024","journal-title":"Int. Urogynecol. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5152\/tud.2020.20432","article-title":"Correlation between the NGF Levels and Questionnaire Forms in Patients Receiving Antimuscarinic Treatment and Those Receiving Onabotulinum Toxin-A Injection","volume":"47","author":"Bayrak","year":"2021","journal-title":"Turk. J. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrurol.2012.178","article-title":"Neurotrophins as Regulators of Urinary Bladder Function","volume":"9","author":"Ochodnicky","year":"2012","journal-title":"Nat. Rev. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s00345-020-03422-6","article-title":"Imbalance of Nerve Growth Factor Metabolism in Aging Women with Overactive Bladder Syndrome","volume":"39","author":"Mossa","year":"2020","journal-title":"World J. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00192-019-04175-6","article-title":"Urinary Metabolomics Predict the Severity of Overactive Bladder Syndrome in an Aging Female Population","volume":"31","author":"Mossa","year":"2019","journal-title":"Int. Urogynecol. J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Covarrubias, C., Cammisotto, P.G., Shamout, S., and Campeau, L. (2023). Decrease in the Ratio proBDNF\/BDNF in the Urine of Aging Female Patients with OAB. Metabolites, 13.","DOI":"10.3390\/metabo13060723"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/clinchem\/14.3.222","article-title":"Estimation of Creatinine by the Jaffe Reaction","volume":"14","author":"Husdan","year":"1968","journal-title":"Clin. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/ijcp.12518","article-title":"Is There a Link between Overactive Bladder and the Metabolic Syndrome in Women? A Systematic Review of Observational Studies","volume":"69","author":"Bunn","year":"2015","journal-title":"Int. J. Clin. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jerez-Roig, J., Booth, J., Skelton, D.A., Gin\u00e9-Garriga, M., Chastin, S.F.M., and Hagen, S. (2020). Is Urinary Incontinence Associated with Sedentary Behaviour in Older Women? Analysis of Data from the National Health and Nutrition Examination Survey. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227195"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cccn.2004.10.002","article-title":"Neurotrophins in Clinical Diagnostics: Pathophysiology and Laboratory Investigation","volume":"352","author":"Nockher","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Severini, C. (2022). Neurotrophic Factors in Health and Disease. Cells, 12.","DOI":"10.3390\/cells12010047"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.3390\/cimb46030160","article-title":"The Influence of Neurotrophins on the Brain-Lung Axis: Conception, Pregnancy, and Neonatal Period","volume":"46","author":"Luppino","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Brattico, E., Bonetti, L., Ferretti, G., Vuust, P., and Matrone, C. (2021). Putting Cells in Motion: Advantages of Endogenous Boosting of BDNF Production. Cells, 10.","DOI":"10.3390\/cells10010183"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zou, Y., Zhang, Y., Tu, M., Ye, Y., Li, M., Ran, R., and Zou, Z. (2024). Brain-Derived Neurotrophic Factor Levels across Psychiatric Disorders: A Systemic Review and Network Meta-Analysis. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 131.","DOI":"10.1016\/j.pnpbp.2024.110954"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Colucci-D\u2019Amato, L., Speranza, L., and Volpicelli, F. (2020). Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207777"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2903","DOI":"10.1002\/brb3.2903","article-title":"BDNF as a Biomarker for Neuropathic Pain: Consideration of Mechanisms of Action and Associated Measurement Challenges","volume":"13","author":"Thakkar","year":"2023","journal-title":"Brain Behav."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5213\/inj.1732794.397","article-title":"Urinary Nerve Growth Factor as a Potential Biomarker of Treatment Outcomes in Overactive Bladder Patients","volume":"21","author":"Suh","year":"2017","journal-title":"Int. Neurourol. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/nau.24113","article-title":"Are Three-day Voiding Diaries Feasible and Reliable? Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Cohort","volume":"38","author":"Cameron","year":"2019","journal-title":"Neurourol. Urodyn."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00192-022-05398-w","article-title":"Current State of Bladder Diary: A Survey and Review of the Literature","volume":"34","author":"Mehta","year":"2023","journal-title":"Int. Urogynecol. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00192-012-1817-9","article-title":"Clinical and Urodynamic Differences among Women with Overactive Bladder According to the Presence of Detrusor Overactivity","volume":"24","author":"Jeong","year":"2013","journal-title":"Int. Urogynecol. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.euros.2022.08.013","article-title":"Randomised Controlled Trials Assessing the Clinical Value of Urodynamic Studies: A Systematic Review and Meta-Analysis","volume":"44","author":"Bodmer","year":"2022","journal-title":"Eur. Urol. Open Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(24)01886-5","article-title":"Invasive Urodynamic Investigations in the Management of Women with Refractory Overactive Bladder Symptoms (FUTURE) in the UK: A Multicentre, Superiority, Parallel, Open-Label, Randomised Controlled Trial","volume":"405","author":"Chapple","year":"2025","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejogrb.2015.11.018","article-title":"Impact of Body Mass Index on Treatment Efficacy of Mirabegron for Overactive Bladder in Females","volume":"196","author":"Krhut","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/7\/429\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:57:14Z","timestamp":1760032634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/7\/429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["metabo15070429"],"URL":"https:\/\/doi.org\/10.3390\/metabo15070429","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}